IPO Observation | Huayuan Biotech Responds to Second Round of Questionnaire, Key Product Under Investigation Still Unresolved, Losses Continuously Expanded
Recently, Wuhan Huayuan Biotech Co., Ltd. (hereinafter referred to as \"Huayuan Biotech\") responded to the second round of questionnaire from the Shanghai Stock Exchange, covering topics such as core